Mental Health News and Research

Latest Mental Health News and Research

Study: IV ibuprofen decreases pain, morphine use in pre and post-operative orthopedic surgery patients

Cumberland Pharmaceuticals Inc. today announced the publication of new data supporting the safety and efficacy of Caldolor® (ibuprofen) Injection in pre and post-operative orthopedic surgery patients. The study, which was published in the August edition of the peer-reviewed journal Pain Medicine, concludes that IV ibuprofen significantly decreased pain and morphine use when compared with placebo.

31 Aug 2010

Uninsured Maine adults with mental illness struggle to get care; Florida continues to push to repeal reform

Kennebec (Maine) Journal: "A growing number of uninsured Mainers with mental illness are falling through the cracks of the health care system because of state budget cuts and financial strains on nonprofits, according to state officials and private agencies. Just as when someone goes without treatment for a toothache and ends up in the ER, the lack of access to regular mental health care means illnesses are getting more expensive and patients are getting sicker, officials said."

31 Aug 2010

AOD Software named to 2010 Inc. 5000 list of fastest-growing private companies

Inc. magazine ranked AOD Software on its annual Inc. 5000, an exclusive ranking of the nation's fastest-growing private companies. The list represents the most comprehensive look at the most important segment of the economy — America's independent-minded entrepreneurs. AOD Software was ranked as number 219 across the Software companies in the country.

31 Aug 2010

BayCare Behavioral Health announces opening of Morton Plant North Bay Hospital Recovery Center in Lutz

As part of its continued commitment to meet the mental health needs of the Tampa Bay community, BayCare Behavioral Health has opened the Morton Plant North Bay Hospital Recovery Center in Lutz.

30 Aug 2010

XIFIN ranked #1,447th on Inc. 5000 list of fastest-growing private companies

XIFIN Inc., the leading provider of revenue cycle management for diagnostic service providers, today announced that the company has been named to the 2010 Inc. 5000 list of fastest-growing private companies for the fourth consecutive year, ranking 1,447th. The company ranked No. 96 in Top Software Companies, and No. 34 in Top Companies in the San Diego Metro Area. The list is widely regarded to include the most innovative and entrepreneurial companies in the nation.

30 Aug 2010

TDWI recognizes CRI as 2010 Best Practices Award Winner

QlikTech today announced that its customer, Centerstone Research Institute, has been recognized as a 2010 Best Practices Award Winner by The Data Warehousing Institute.

30 Aug 2010

West Physics Consulting ranked #2230 on fourth annual Inc. 5000 list

Inc. magazine has ranked West Physics Consulting, LLC No. 2230 on its fourth annual Inc. 5000 list, an exclusive ranking of the nation's fastest-growing private companies. The list represents the most comprehensive look at the most important segment of the economy -- America's independent-minded entrepreneurs. Music website Pandora, convenience store chain 7-Eleven, Brooklyn Brewery, and Radio Flyer, maker of the iconic children's red wagon, are among the prominent brands featured on this year's list.

30 Aug 2010

Latest achievements in brain research and treatment for mental disorders

Mental disorders, such as depression, anxiety disorders, addiction and schizophrenia are the core challenge of most health care systems around the world. In the EU alone, each year 27% of the total adult population - this corresponds to 83 Million citizens - suffer from mental disorders. Depression alone affects almost 20 million ranking in the EU as the most disabling disorder of all diseases.

30 Aug 2010

CAMH welcomes Ontario's narcotics strategy to address inappropriate use of prescription opioids

The Government of Ontario's narcotics strategy will address the root causes of a significant and growing health problem - the inappropriate use of prescription opioids. The Centre for Addiction and Mental Health (CAMH) welcomes the strategy announced by The Honourable Deb Matthews, Minister of Health and Long-Term Care.

30 Aug 2010

23rd ECNP Press conference on impact of circadian rhythms on human brain

All humans are synchronised to the rhythmic light-dark changes that occur on a daily basis. Rhythms in physiological and biochemical processes and behavioural patterns persist in the absence of all external 24-hour signals from the physical environment, with a period that is close to 24 hours

30 Aug 2010

23rd ECNP Congress press conference

The incidence of psychotic disorders varies greatly across places and demographic groups, as do symptoms, course, and treatment response across individuals. High rates of schizophrenia in large cities, and among immigrants, cannabis users, and traumatised individuals reflect the causal influence of environmental exposures. This, in combination with progress in the area of molecular genetics, has generated interest in more complicated models of schizophrenia aetiology that explicitly posit gene-environment interactions.

30 Aug 2010

Researchers examine functions of neuronal diversity

Much like snowflakes, no two neurons are exactly alike. But it's not the size or shape that sets one neuron apart from another, it's the way it responds to incoming stimuli. Carnegie Mellon University researchers have discovered that this diversity is critical to overall brain function and essential in how neurons process complex stimuli and code information.

30 Aug 2010

Forest Laboratories reveals top-line results from cariprazine Phase II clinical trial for bipolar depression

Forest Laboratories, Inc. and Gedeon Richter Plc. today announced preliminary top-line results from an 8-week Phase II clinical trial of the novel, investigational antipsychotic agent cariprazine for the treatment of bipolar depression. Cariprazine is currently undergoing Phase III trials for separate indications of schizophrenia and bipolar mania.

30 Aug 2010

An overview of Schizophrenia and psychotic disorders

Schizophrenia and related psychotic disorders are a chronic and often disabling condition. Despite modern treatment techniques they still present an enormous burden to the patients and their relatives and take a serious toll in terms of human suffering and societal expenditure.

30 Aug 2010

Researchers find smoked cannabis reduces chronic neuropathic pain

For people suffering chronic pain, smoked cannabis reduces pain, improves mood and helps sleep, according to new research published in CMAJ.

30 Aug 2010

CAMH to work on blueprint from Legislative Assembly's committee for mental health services

Legislative Assembly's committee on mental health and addictions has provided Ontario with a blueprint for improving care, says the province's largest mental health and addictions hospital.

30 Aug 2010

Scientist suggests guidelines to safeguard physical health in college

College can be some of the best years of a person's life. But it is also a critical time, a time when students need to be aware of their health and safety. For women, many on their own for the first time in their lives, developing the ability to safeguard their emotional and physical health is paramount.

30 Aug 2010

GWAS finds new genetic link between Parkinson's disease and inflammation

A hunt throughout the human genome for variants associated with common, late-onset Parkinson's disease has revealed a new genetic link that implicates the immune system and offers new targets for drug development.

30 Aug 2010

New non-invasive method to diagnose osteoarthritis

Researchers at New York University have developed an innovative way to look at the development of osteoarthritis in the knee joint-one that relies on the examination of sodium ions in cartilage. Their work, which appears in the Journal of Magnetic Resonance, may provide a non-invasive method to diagnose osteoarthritis in its very early stages.

30 Aug 2010

Study finds common risk factors linked with painkiller addiction

A new Geisinger study begins to unlock the puzzle of painkiller (opioid) addiction - why some people are more likely to become addicted than others. Geisinger investigators have found that patients with four common risk factors have a significantly higher risk of addiction. In addition, a history of severe drug dependence and drug abuse compounds the risk.

30 Aug 2010